Oaktree Acquisition Corp. III Life Sciences
OACCW | NASDAQ
$0.88
+$0.01 (+1.15%)
May 20, 2026, 11:02 AM ET · Market open
Market Data
Market Cap $20.87M
Enterprise Value $20.33M
Beta 0.94
Average Volume 5.88K
Shares Outstanding (Diluted) 19.2M
Shares Change YoY -21.9%
Institutional Ownership N/A
Exchange NASDAQ
ISIN KYG6717R1121
Price Performance
Price Change 1M 1.1%
Price Change 3M 6.4%
Price Change 6M 17.1%
Price Change YTD -7.4%
Price Change 1Y 10.0%
Price Change 3Y 15.8%
Price Change 5Y 15.8%
1M CAGR (ann.) N/A
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR N/A
Valuation
PE Ratio 3.03
Forward PE N/A
PEG Ratio 0.02
Forward PEG N/A
PS Ratio N/A
Forward PS N/A
PB Ratio -2.99
P/FCF Ratio -49.54
P/Adj. FCF Ratio -49.54
P/OCF Ratio -44.00
EV/Sales N/A
EV/EBIT -27.08
EV/EBITDA -16.84
EV/FCF -46.61
Earnings Yield 33.0%
FCF Yield -2.0%
Adj. FCF Yield -2.0%
Financial Health
Net Cash $1.28M
Total Debt $0
Cash & Short-Term Investments $1.28M
Total Assets $204.83M
Current Ratio 0.87
Quick Ratio 0.87
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 1.39
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 3.4%
Return on Equity 4.9%
Return on Invested Capital -0.6%
Return on Capital Employed -0.6%
Return on Tangible Assets 3.4%
Fair Value Estimates
Graham Number $8.17
Graham Upside 828.4%
Lynch Fair Value N/A
Lynch Upside N/A
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-436.24K
Free Cash Flow $-436.24K
Adj. Free Cash Flow $-436.24K
FCF Per Share -$0.02
OCF Per Share -$0.02
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-1.21M
EBITDA $-1.21M
Net Income $7.02M
EPS (Diluted) $0.29
Revenue / Employee N/A
Profit / Employee N/A
Employees 0
Add to Watchlist
Select watchlists to add or remove OACCW